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Abstract
Background: Differentiating amnestic mild cognitive impairment (aMCI) from normal cognition is difficult in
clinical settings. Self-reported and informant-reported memory complaints occur often in both clinical groups,
which then necessitates the use of a comprehensive neuropsychological examination to make a differential
diagnosis. However, the ability to identify cognitive symptoms that are predictive of aMCI through informant-based
information may provide some clinical utility in accurately identifying individuals who are at risk for developing
Alzheimer’s disease (AD).
Methods: The current study utilized a case-control design using data from an ongoing validation study of the
Alzheimer’s Questionnaire (AQ), an informant-based dementia assessment. Data from 51 cognitively normal (CN)
individuals participating in a brain donation program and 47 aMCI individuals seen in a neurology practice at the
same institute were analyzed to determine which AQ items differentiated aMCI from CN individuals.
Results: Forward stepwise multiple logistic regression analysis which controlled for age and education showed
that 4 AQ items were strong indicators of aMCI which included: repetition of statements and/or questions [OR
13.20 (3.02, 57.66)]; trouble knowing the day, date, month, year, and time [OR 17.97 (2.63, 122.77)]; difficulty
managing finances [OR 11.60 (2.10, 63.99)]; and decreased sense of direction [OR 5.84 (1.09, 31.30)].
Conclusions: Overall, these data indicate that certain informant-reported cognitive symptoms may help clinicians
differentiate individuals with aMCI from those with normal cognition. Items pertaining to repetition of statements,
orientation, ability to manage finances, and visuospatial disorientation had high discriminatory power.
Background
The process of differentiating age-associated memory
decline from those who might have a clinically signifi-
cant disorder of memory and cognition is difficult. In
particular, distinguishing individuals with amnestic mild
cognitive impairment (aMCI) from those who are cogni-
tively normal (CN) is challenging, as memory and cogni-
tive complaints are often reported in both groups from
both the patient and informants [1]. Given that the cur-
rent diagnostic criteria for aMCI include subjective
(patient and/or family report of decline) and objective
(neuropsychological testing) evidence of memory
decline, a clinician’s initial impression from a relatively
short office visit may not allow for an accurate assess-
ment [2].
Amnestic MCI was first characterized as a syndrome
consisting of memory performance at or below 1.5 stan-
dard deviations (SD) on age- and education-adjusted
normative values on a verbal memory test along with
subjective memory complaints, preserved global cogni-
tion, and preserved activities of daily living [3]. The
diagnostic criteria for MCI have since been refined to
differentiate between amnestic and non-amnestic forms,
with the latter showing performance at or below 1.5 SD
on a test or test(s) in one or more domains other than
memory. Both amnestic and non-amnestic MCI can be
further classified as single or multiple domain MCI
depending upon the number of cognitive domains that
show test performance(s) at or below 1.5 SD [4].
Several studies have investigated the clinical course
and presentation of individuals who have self- and infor-
mant-reported memory complaints [5-8]. Some evidence
suggests that individuals who are cognitively normal and
have subjective memory complaints demonstrate MRI
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[9]. Other studies have demonstrated that an infor-
mant’s report of an individual’s cognitive status is valid
and highly accurate in the very early stages of AD [6].
Although the diagnostic criteria for aMCI do not
include functional impairment, previous studies have
found that aMCI patients may have difficulty with
higher level daily activities, such as balancing a check-
book, and may show mild, but not significant, difficulty
in daily functioning [1,10].
Utilizing additional information with added discrimi-
natory power can aid in identifying individuals at risk
for developing Alzheimer’s disease (AD), a task of
greater interest now, with emerging early AD treatments
[10,11]. To accomplish this, identifying certain cognitive
symptoms that may yield greater diagnostic accuracy
than subjective memory complaints alone is necessary.
A recent pilot study found that the Alzheimer’sQ u e s -
tionnaire (AQ), an informant-based questionnaire
designed for use in primary care settings, has both high
sensitivity [87.00 (77.00 - 94.00)] and specificity [94.00
(84.00, 99.00)] for aMCI [12].
The intent of this study is to determine which AQ
items are predictive of aMCI. By identifying cognitive
symptoms beyond subjective memory complaints, indivi-
duals at risk for developing AD may be identified more
quickly so that further diagnostic testing and subsequent
treatment may be initiated sooner in the disease process.
Method
Study Sample
Data from 98 individuals (47 aMCI, 51 CN) were taken
from an ongoing validation study of the AQ. Both aMCI
and CN individuals were drawn from the same geo-
graphic population (Sun City, AZ). A case-control
design was used for this study as the aMCI participants
were drawn from the practice of a neurologist specializ-
ing in dementia and memory disorders. The clinician’s
diagnosis was used as the gold standard for aMCI parti-
cipants, based on cognitive and medical history, infor-
mant interview, and neuropsychological testing utilizing
Petersen criteria [3]. Individuals whose performance was
1.5 standard deviations (SD) below age- and education-
corrected means on a delayed recall measure of verbal
memory were classified as aMCI. Individuals with both
single and multiple domain aMCI were included in the
analysis. Multiple domain aMCI cases were classified as
those with memory performance 1.5 SD below age- and
education-corrected means with performance in another
cognitive domain (e.g., executive functions) also falling
1.5 SD below age- and education-corrected means.
CN participants were drawn from a brain and body
donation program in which informants were given the AQ
as part of the participants’ annual assessment. Both aMCI
and CN participants were recruited consecutively. CN par-
ticipants were defined as having no demonstrable cogni-
tively-based limitations of activities of daily living through
an informant interview by a physician. In addition, all CN
participants scored above 1.5 SD on age- and education-
corrected means on a battery of neuropsychological tests
and received global CDR rating of 0 [13]. Consensus diag-
nosis with a neurologist, geriatric psychiatrist, and neurop-
sychologist was used as the gold standard in determining
CN status. The AQ was not utilized in the differential
diagnosis for aMCI individuals and was not utilized in the
consensus diagnosis for CN individuals. Interviews with
the participant and informant and review of medical
records were used to exclude those with symptomatic or
severe brain-related neurological or psychiatric illness.
Excluded conditions included mental retardation, epilepsy,
cerebral infarction or hemorrhage, multiple sclerosis, brain
tumor, major depressive disorder (unipolar or bipolar),
schizophrenia, traumatic brain injury, and substance
abuse. Collateral informants provided additional informa-
tion on cognitive and functional changes.
IRB approval was waived by the Sun Health IRB as the
study fell under their categorization of research invol-
ving the use of educational tests (cognitive, diagnostic,
aptitude, achievement), survey procedures, interview
procedures or observation of public behavior which is
not subject to review and does not require informed
consent. None of the authors on this paper served on
the Sun Health IRB and the granting bodies that pro-
vided funding for this study did not require any type of
ethics review.
Neuropsychological Tests
Rey Auditory Verbal Learning Test [14]
A list of 15 words is read aloud to the individual after
which they are asked to recall as many words as possible
in any order. This is done 5 times. After the fifth trial, a
new 15-word list is read aloud to the individual after
which they are asked to recall as many words as possible
in any order. They are then asked to recall the words
they remember from the list that was read to them 5
times. After a 20 minute delay, they are again asked to
recall words from the list that was read 5 times.
WMS-R Logical Memory [15]
A short fictional story is read to the individual after
which they are asked to repeat as much of the story as
they can remember. After a 20 minute delay, they are
asked to recall the story again.
Trails A [16]
The individual is instructed to draw a line that connects
circled numbers in consecutive order.
Trails B [16]
The individual is asked to draw a line that connects
circled numbers and circled letters in consecutive order
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- B - 3 - C, etc).
Controlled Oral Word Association Test [14]
Individuals are given one minute to verbally produce as
many words as they can that begin a given letter. One
minute per word is given.
Animal Fluency [14]
Individuals are given one minute to verbally produce as
many names of animals as they can.
Stroop Color/Word [17]
The individual is presented with 5 columns of the words
“blue”, “red”,a n d“green” presented in random order.
The words are printed in an ink that is incongruent
with the actual word itself (ie, the word “blue” is printed
in red ink). The individual is then asked to identify the
color of the ink the word is printed in. There is a 45-
second time limit in which the individual must give as
many correct responses as possible.
Judgment of Line Orientation [18]
Individuals are asked to match a set of two lines set at
varying angles and lengths to a reference of lines placed
below each stimulus card for each trial.
The Alzheimer’s Questionnaire (AQ)
The Alzheimer’s Questionnaire (AQ) is a 21-item, infor-
mant-based dementia assessment designed for ease of
use in a primary care setting. AQ items are divided into
five domains including Memory, Orientation, Functional
Ability, Visuospatial Ability, and Language. Items are
posed in a yes/no format with the sum of ‘yes’ items
equaling the total AQ score (0-27). Six items known to
be predictive of a clinical AD diagnosis are weighted
more heavily in the total score by being worth two
points rather than one.
Statistical Analysis
Data from the individual AQ items were first analyzed
using the Chi-square statistic to determine if there were
significant differences in positive response frequencies
between aMCI and CN individuals for each item. Multi-
ple forward stepwise logistic regression was carried out
to determine the predictive ability of individual AQ items
while adjusting for the effects of age and education. For
this analysis, clinical status (aMCI) was the outcome and
the individual AQ items were entered as predictors. Cri-
teria for retaining predictor variables was set to alpha <
.05. Nagelkerke’sR
2 was used to determine the amount
of variance accounted for by the logistic model.
Systat 13.0 was used to carry out all analyses.
Results
Demographic characteristics of the study sample are dis-
played in Table 1. The CN group was older and slightly
more educated than the aMCI group. Males and females
had relatively equal representation across groups. Chi-
square analysis showed significant differences in
response frequencies for all but two AQ items (Table 2).
Results from the multiple forward stepwise logistic
regression analysis, which adjusted for age and educa-
tion, are displayed in Table 3; only the AQ items that
were included in the stepwise model are shown. This
model yielded four AQ items as strong predictors of
aMCI, which are listed in Table 3 with their associated
odds ratios (OR), 95% confidence intervals, and p-values.
The resulting stepwise logistic model yielded a Nagelk-
erke R
2 of 0.71 indicating that a large proportion of the
variance between aMCI and CN individuals was
accounted for by the four AQ items.
In order to more accurately characterize the clinical
validity of these findings, a second non-stepwise logistic
regression analysis was carried out which used only the
four significant AQ items while correcting for age and
education. This model yielded sensitivity of 80.30 (67.00,
89.53) and specificity of 81.80 (69.67, 90.37) with an
area under the curve (AUC) value of 0.94 (0.89, 0.99).
Discussion and Conclusions
The results of the study indicate that the four infor-
mant-reported items listed immediately above are highly
predictive of aMCI. These items are memory-related,
and also suggest some degree of impairment in higher-
level functional abilities. The use of informant-supplied
information is a widely-used and highly valid method of
assessing an individual’s cognitive and functional abil-
ities [5,7]. Relative to other informant-based instruments
[19-22] the AQ takes substantially less time to adminis-
ter [12], a fact of importance to clinicians with very lim-
ited time [23].
For clinicians who see patients with subjective mem-
ory complaints, accurate identification of those who
need further evaluation is critical to cost containment
and resource management. A significant proportion of
older adults present with subjective memory complaints
[24,25], and these complaints can precede the onset of
clinical AD [26]. The large and growing number of
older adults underscores the importance of utilizing
brief and accurate screening measures. Additionally, as
Table 1 Demographic Characteristics
CN aMCI Total
N5 14 79 8
Male (%) 43 57 50
Female (%) 57 43 50
Age 78.59 (6.72) 74.36 (7.19) 76.56 (7.23)
Education 15.04 (3.03) 14.43 (2.51) 14.74 (2.79)
MMSE 28.47 (1.27) 26.89 (1.90) 27.71 (1.78)
Mean (sd)
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matic to disease-modifying, identifying individuals who
are at-risk or are in the earliest stages of the disease will
be crucial in determining and improving disease out-
come [1].
There are some limitations to this study. The first is
that the confidence intervals for the odds ratios of the
statistically significant AQ items were relatively wide,
indicating decreased statistical power. Although the
sample was large enough to yield robust odds ratios for
the four AQ items, a larger sample size might provide a
more accurate estimate of effect size. In addition, the R
2
value may not truly represent the amount of variance
accounted for by the model. The reason for this is that
R
2 values in logistic models are approximations of lin-
ear-based R
2 measures and are not fully equivalent. In
addition, R
2 measures used in logistic models are prone
to bias when used with small sample sizes and may
Table 2 Frequency of Informant-Reported Cognitive Symptoms for aMCI and CN Groups
Item c
2 p-
value
Yes -
aMCI
Yes -
CN
Does the patient have memory loss? 25.99 <
.0001
46/47 27/51
If so, is their memory worse than a few years ago? 6.30 .01 33/47 23/51
Does the patient repeat questions or statements or stories in the same day? 37.60 <
.0001
33/47 5/51
Have you had to take over tracking events or appointments, or does the patient forget appointments? 21.77 <
.0001
30/47 9/51
Does the patient misplace items more than once a month, or does the patient misplace objects so that he/she
cannot find them?
11.95 .005 33/47 18/51
Does the patient suspect others of moving, hiding, or stealing items when he/she cannot find them? 3.53 .06 7/47 2/51
Does the patient frequently have trouble knowing the day, date, month, year, and time; or does the patient
reference a newspaper or calendar for the date more than once a day?
17.79 <
.0001
18/47 2/51
Does the patient become disoriented in unfamiliar places? 17.78 <
.0001
24/47 6/51
Does the patient become more confused when travelling outside the home? 9.87 .0017 21/47 8/51
Excluding physical limitations, does the patient have trouble handling money (tips, calculating change)? 5.72 .02* 5/47 0/51
Excluding physical limitations, does the patient have trouble paying bills or doing finances; or are family members
taking over because of concerns about ability?
19.91 <
.0001
21/47 3/51
Does the patient have trouble remembering to take medications or tracking medications taken? 16.76 <
.0001
19/47 3/51
Is the patient having difficulty driving; or are you concerned about the patient’s driving; or has the patient stopped
driving for reasons other than physical limitations?
0.50 .48 11/47 9/51
Is the patient having trouble using appliances? 4.31 .05* 6/47 1/51
Excluding physical limitations, is the patient having difficulty in completing home repair or housekeeping tasks? 9.16 .003 10/47 1/51
Is the patient getting lost in familiar surroundings? 4.31 .04 6/47 1/51
Does the patient have a decreased sense of direction? 19.99 <
.0001
24/47 5/51
Does the patient have trouble finding words other than names? 6.81 .009 24/47 13/51
Does the patient confuse names of family members or friends? 15.94 <
.0001
20/47 4/51
Does the patient have difficulty recognizing people familiar to him/her? 6.94 .009 6/47 0/51
* Fisher’s exact test p-value was used due to expected cell counts less than 5
Table 3 Multiple Forward Stepwise Logistic Regression Analysis of AQ Items
AQ Item Odds
Ratio
95% CI p-
value
Does the patient repeat questions or
statements or stories in the same day?
13.12 (3.02,
57.66)
0.001
Does the patient frequently have trouble knowing the day, date, month, year, and time; or does the patient reference
a newspaper or calendar for the date more than once a day?
17.97 (2.63,
122.77)
0.003
Excluding physical limitations, does the patient have trouble paying bills or doing finances; or are family members
taking over because of concerns about ability?
11.60 (2.10,
63.99)
0.005
Does the patient have a decreased sense of direction? 5.84 (1.09,
32.30)
0.04
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accounted for [27]. Another limitation is that the AQ
itself requires the use of an informant. In some cases, a
patient may come to a physician’s office alone or they
m a yn o th a v ear e l i a b l ei n f o r m a n ta v a i l a b l et od ot h e
assessment. Although several patient-based cognitive
assessments, such as the Mini Mental State Exam [28],
can be used, they are subject to confounding factors
such as cultural effects and low education [29-31].
Finally, the study sample was homogenous with respect
to ethnicity, as all subjects were Caucasian, so it is
unclear whether these results are applicable to an ethni-
cally diverse population.
In addition, the ability of other widely-used informant-
based instruments to accurately identify clinical aMCI
has not been established. The validity and accuracy of
the AD8 has been established in clinical AD and in indi-
viduals with a CDR global rating 0.5 which is considered
“very mild dementia” [32]. It is important to note that
this categorization (CDR = 0.5) does not necessarily
equate to a clinical diagnosis of aMCI so it is uncertain
whether the AD8 can accurately identify clinically-
defined aMCI cases. In addition, a recent study demon-
strated that the IQCODE does not have high sensitivity
in the detection of aMCI [33]. As mentioned earlier, a
previous pilot study of the AQ demonstrated high sensi-
tivity and specificity for aMCI when compared to cogni-
tively normal individuals. The results of the current
study showed that four statistically significant AQ items
accounted for large proportion of the variance between
aMCI and CN individuals and also yielded high sensitiv-
ity and specificity in differentiating the two groups.
Overall, the results of this study indicate that certain
AQ items can differentiate individuals with aMCI from
those experiencing age-associated changes in memory
and cognition. As assessed by the AQ, difficulties with
orientation to time, repetition of questions and state-
ments, difficulties in managing finances, and visuospatial
disorientation were all significant predictors of aMCI as
diagnosed by an expert in memory disorders.
Given that memory complaints are commonly
reported by elderly patients and their family members
[7], a means to quickly and accurately identify indivi-
duals who may be in the early stages of AD and in need
of further evaluation is critical to not only cost contain-
ment and resource management, but also to earlier diag-
nosis in order to improve disease outcome. These data
indicate that problems with orientation to time, repeat-
ing statements and questions, difficulty managing
finances, and trouble with visusospatial orientation may
accompany memory deficits in aMCI. From a clinical
standpoint, these findings are important as it will allow
clinicians to more easily and accurately determine which
individuals require further assessment of cognitive
problems.
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